Free Trial

Harvard Bioscience (HBIO) SEC Filings & 10K Form

Harvard Bioscience logo
$0.52 -0.01 (-2.60%)
Closing price 08/28/2025 04:00 PM Eastern
Extended Trading
$0.51 -0.01 (-1.77%)
As of 08:00 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Harvard Bioscience SEC Filings

DateFilerForm TypeView
08/19/2025
1:39 PM
Green James W (Reporting)
Harvard Bioscience (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/13/2025
3:30 PM
Harvard Bioscience (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/11/2025
8:09 PM
Duke John D (Reporting)
Harvard Bioscience (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/11/2025
3:30 PM
Harvard Bioscience (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/11/2025
3:30 PM
Harvard Bioscience (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/11/2025
6:01 AM
Harvard Bioscience (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/07/2025
9:00 AM
Harvard Bioscience (Subject)
Leviticus Partners LP (Filed by)
Form SCHEDULE 13G/A
07/25/2025
8:37 PM
Benson Seth Benjamin (Reporting)
Harvard Bioscience (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
07/25/2025
8:38 PM
Benson Seth Benjamin (Reporting)
Harvard Bioscience (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/18/2025
3:33 PM
Eade Katherine A. (Reporting)
Harvard Bioscience (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/18/2025
3:31 PM
Gagnon Robert E. (Reporting)
Harvard Bioscience (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
07/18/2025
3:32 PM
Gagnon Robert E. (Reporting)
Harvard Bioscience (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/17/2025
7:12 PM
BlackRock, Inc. (Filed by)
Harvard Bioscience (Subject)
Form SCHEDULE 13G/A
07/17/2025
6:01 AM
Harvard Bioscience (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/27/2025
3:45 PM
Harvard Bioscience (Filer)
Form 8-K/A
06/23/2025
3:46 PM
Harvard Bioscience (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/13/2025
3:45 PM
Harvard Bioscience (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/09/2025
8:08 PM
Duke John D (Reporting)
Harvard Bioscience (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
06/02/2025
4:00 PM
Harvard Bioscience (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/30/2025
10:50 AM
Harvard Bioscience (Subject)
Leviticus Partners LP (Filed by)
Form SCHEDULE 13G/A
05/27/2025
3:36 PM
Harvard Bioscience (Filer)
Form SD
Specialized Disclosure Report  
05/14/2025
11:28 AM
Harvard Bioscience (Subject)
Leviticus Partners LP (Filed by)
Form SCHEDULE 13G/A
05/12/2025
3:46 PM
Harvard Bioscience (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/12/2025
6:00 AM
Harvard Bioscience (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/08/2025
11:45 AM
Harvard Bioscience (Subject)
WEBER CAPITAL MANAGEMENT LLC /ADV (Filed by)
Form SCHEDULE 13G/A
04/21/2025
3:45 PM
Harvard Bioscience (Filer)
Form DEF 14A
04/21/2025
3:45 PM
Harvard Bioscience (Filer)
Form DEFA14A
04/10/2025
3:46 PM
Harvard Bioscience (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/08/2025
8:49 AM
Harvard Bioscience (Subject)
Leviticus Partners LP (Filed by)
Form SCHEDULE 13G/A
03/21/2025
3:49 PM
Green James W (Reporting)
Harvard Bioscience (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/21/2025
3:50 PM
Cote Jennifer (Reporting)
Harvard Bioscience (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/17/2025
9:33 AM
Harvard Bioscience (Subject)
Leviticus Partners LP (Filed by)
Form SCHEDULE 13G
03/12/2025
6:00 AM
Harvard Bioscience (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/10/2025
3:56 PM
Harvard Bioscience (Subject)
WEBER CAPITAL MANAGEMENT LLC /ADV (Filed by)
Form SCHEDULE 13G
02/04/2025
9:37 AM
Harvard Bioscience (Subject)
Leviticus Partners LP (Filed by)
Form SCHEDULE 13G/A
12/31/2024
3:01 PM
Cote Jennifer (Reporting)
Harvard Bioscience (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/31/2024
3:02 PM
Green James W (Reporting)
Harvard Bioscience (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/29/2024
11:15 PM
Harvard Bioscience (Filer)
Form EFFECT
12/06/2024
6:45 AM
Harvard Bioscience (Filer)
Form S-3
Registration statement under Securities Act of 1933  
11/14/2024
11:31 AM
272 Capital LP (Filed by)
Harvard Bioscience (Subject)
Form SC 13G/A
11/08/2024
3:45 PM
Harvard Bioscience (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
This stock could leave NVDA in the dust (Ad)

Investing Legend Hints the End May be Near for These 3 Iconic Stocks Futurist Eric Fry say Amazon, Tesla and Nvidia are all on the verge of major disruption. To help protect anyone with money invested in them, he's sharing three exciting stocks to replace them with. He gives away the names and tickers completely free in his brand-new "Sell This, Buy That" broadcast.tc pixel

Click to get the full details on Eric Fry's "Nvidia alternative" right here.
11/07/2024
6:02 AM
Harvard Bioscience (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:HBIO) was last updated on 8/29/2025 by MarketBeat.com Staff
From Our Partners